Hendrik Jan Thibaut

This paper develops a high-throughput imaging platform for RV-C research and antiviral drug discovery, identifying inhibitors through compound screening.

This study demonstrates that enterovirus 2A protease is critical for viral replication and evasion of host antiviral responses through multiple mechanisms.

This study shows that antigenic imprinting limits neutralizing antibody responses to new SARS-CoV-2 variants in hamsters, suggesting challenges for vaccine efficacy against emerging subvariants.

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

This paper develops a single-dose YF17D-vectored SARS-CoV-2 vaccine candidate that induces neutralizing antibodies and protects against infection in hamsters.